Stay updated on REL-1017 Monotherapy for MDD Clinical Trial
Sign up to get notified when there's something new on the REL-1017 Monotherapy for MDD Clinical Trial page.

Latest updates to the REL-1017 Monotherapy for MDD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0; the study record content remains unchanged.SummaryDifference0.1%

- Check22 days agoChange DetectedA site-wide notice was added stating that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference0.8%

- Check29 days agoChange DetectedThe ClinicalTrials.gov page footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry labeled v3.7.0 is added to the history, replacing the previous v3.6.6 and signaling an update to the study record.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry (v3.6.6) has been added to the history and the previous revision (v3.6.5) has been removed. This updates the historical record for the study.SummaryDifference0.1%

Stay in the know with updates to REL-1017 Monotherapy for MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REL-1017 Monotherapy for MDD Clinical Trial page.